North America remains a dominant regional market for FDA-approved weight-loss devices due to rising obesity rates, increasing healthcare expenditure, and widespread access to advanced treatment options. The region benefits from a well-established healthcare ecosystem, robust regulatory frameworks, and ongoing investments in obesity management technologies. Market Overview The FDA Grade...